№ files_lp_3_process_7_061767
File format: docx
Character count: 10754
File size: 68 KB
Guidance document detailing the processes, rights, and responsibilities for patients receiving medicines through homecare services in the UK.
Year:
2026
Region / City:
United Kingdom
Subject:
Homecare medication services
Document type:
Charter / Guidance
Organization:
NHS England
Author:
NHS England
Target audience:
Patients receiving homecare medicines
Period of applicability:
Ongoing from 2026
Approval date:
2026
Responsibilities outlined:
Patient, hospital team, GP, homecare provider
Consent requirement:
Yes
Information provided:
Homecare processes, delivery arrangements, patient rights
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2022
Region / City:
Arkansas
Theme:
Medicaid, Home and Community-Based Services
Document Type:
Program Guidelines
Agency:
Arkansas Medicaid
Author:
Division of Provider Services and Quality Assurance
Target Audience:
Healthcare providers and service organizations
Period of Action:
Ongoing, based on program criteria
Approval Date:
10-1-22
Date of Amendments:
10-1-22
Note:
Year
Year:
2011
Region / City:
England
Topic:
Homecare Services, Patient Registration
Document Type:
Template
Organization / Institution:
Royal Pharmaceutical Society
Author:
NHMC
Target Audience:
Healthcare professionals, Homecare providers
Period of Validity:
Not specified
Approval Date:
17 October 2017
Year:
2013
Region / city:
UK
Topic:
Homecare Medicines
Document type:
Charter
Author:
NHS
Target audience:
Patients receiving homecare services, healthcare professionals
Period of validity:
N/A
Approval date:
N/A
Date of changes:
2013
Note:
Year
Target Audience:
IT and database administration teams
Supported SQL Server Version:
SQL Server 2017 Standard 64-bit
File Download Method:
WinSCP / SFTP
Log Backup Frequency:
Every 10 minutes
Replica Database Setup:
Quest LiteSpeed for SQL Server
Service Level:
Best effort
Support Contact:
HCHB Customer Services
Log Shipping Process:
Manual or automated
Security Features:
Encrypted transmission
System Requirements:
Modern dual-core processor, 16 GB RAM (for databases < 50 GB)
Automated Transaction Log Restore Process:
SQL Server job
Job Title:
Pharmacy Technician Specialist, Homecare Medicines Management
Reports to:
Pharmacy Procurement Manager
Accountable to:
Pharmacy Procurement Manager
Grade:
Band 6
Unit/Department:
Pharmacy
Location:
Not specified
Qualifications:
BTEC in Pharmaceutical Science, NVQ Level 3 in Pharmacy Services or equivalent
Experience:
Minimum 3 years post-qualified experience, supervisory/management experience, hospital pharmacy experience
Skills:
Accuracy checking, training and assessing staff, SOP development, stock control systems, communication skills, problem solving, analytical skills, time management
Core Values:
Enthusiastic, reliable, motivated, confident, integrity, patient confidentiality, empathy, commitment to professional development
Core Behaviours:
Team working, flexibility, initiative, influence, motivation, analytical and prioritisation skills
Responsibilities:
Manage and develop homecare medicines management services, coordinate with healthcare teams, oversee service specifications, provide specialist advice, ensure compliance with SOPs, GMP, and COSHH, training and development of staff, quality and financial reporting, tender processes, risk management
Type:
Job description / professional role specification
Target Audience:
Pharmacy staff, healthcare administrators
Period of Service:
Ongoing
Year:
2026
Region / Country:
United Kingdom (England, Northern Ireland, Scotland, Wales)
Document Type:
Reporting Form
Organization:
NHS / Homecare Providers
Target Audience:
Patients, Carers, Healthcare Staff
Topics:
Patient complaints, Incident reporting, Medicines, Medical devices
Period of Use:
Current
Date Issued:
2026
Instructions Included:
Yes
Data Collected:
Personal details, Incident description, Medicines, Medical devices
Year:
2023
Region / city:
Australia
Subject:
Pharmaceutical compounding guidelines
Document Type:
Guideline
Organization / Institution:
Pharmacy Board of Australia
Author:
Pharmacy Board of Australia
Target Audience:
Registered pharmacists, education providers, employers
Period of validity:
Indefinite
Approval Date:
Not specified
Date of amendments:
Not specified
Year:
2016
Region / City:
Australia
Topic:
Pharmacy, Medicine Compounding
Document Type:
Consultation Response
Organization:
Pharmaceutical Society of Australia
Author:
Dr Lance Emerson, Chief Executive Officer
Target Audience:
Pharmacists, Pharmacy Regulators
Period of Validity:
Indefinite
Approval Date:
1 February 2016
Date of Amendments:
None
Contextual Description:
Document is a public consultation response discussing terminology issues and proposed updates regarding compounded parenteral medicines, primarily aimed at Australian pharmacists.
Organisation:
Canberra Health Services
Document type:
Guideline
Reference number:
CHS25/225
Jurisdiction:
Australian Capital Territory
Healthcare setting:
Public health services
Subject area:
Medication management
Professional scope:
Nursing and midwifery practice
Approved by:
Drug and Therapeutics Committee
Target professionals:
Registered nurses and registered midwives
Patient groups:
Adults, children 12 years or older, and selected medicines for children under 12 years
Exclusions:
Neonates, Special Care Nursery patients, Neonatal Intensive Care Unit patients
Regulatory framework:
Australian medicines scheduling (Schedules 2, 3, 4, and 8)
Content components:
Governance, safe use, documentation, approved medicine lists
Year:
2023
Region / city:
European Union
Topic:
Pharmaceutical technology development
Document type:
Briefing document
Organization:
European Medicines Agency
Author:
Not specified
Target audience:
Pharmaceutical experts, regulatory authorities
Period of validity:
Not specified
Approval date:
Not specified
Date of modifications:
Not specified
This document is a briefing source for discussing pharmaceutical technology and regulatory aspects at a QIG 1:
1 meeting.
Year:
2023
Country:
Australia
Topic:
Opioid dependence treatment
Document type:
Information overview
Program:
ODT Community Pharmacy Program
Administering body:
Pharmacy Programs Administrator
Related scheme:
Pharmaceutical Benefits Scheme
Legislative framework:
National Health (Highly specialised drugs program) Special Arrangement 2021
Target audience:
Community pharmacists and hospital pharmacists
Effective date:
1 July 2023
Funding period:
2023–24 to 2026–27
Medicines covered:
Methadone, buprenorphine, buprenorphine with naloxone
Regulatory classification:
Schedule 8 controlled drugs
Source type:
Government health program guidance
Document type:
Q&A guidance
Jurisdiction:
Japan
Subject:
Import and shipment of medicines and medical devices
Issuing authority:
Ministry of Health, Labour and Welfare
Intended users:
Individuals importing or sending medicines for personal use
Scope:
Prescription medicines, injections, syringes, and medical devices
Import purpose:
Personal use
Regulatory framework:
Pharmaceutical and Medical Device regulations
Application system:
Online Import Confirmation system
Related forms:
Import Confirmation Application Form (Form 12); Explanation of Pharmaceutical Product (Form 13)
Year:
2024
Region / city:
Denmark
Topic:
Medicine, Health Economics
Document type:
Template
Organization / institution:
Danish Medicines Council
Author:
Danish Medicines Council
Target audience:
Pharmaceutical companies
Period of validity:
Ongoing
Approval date:
10 September 2024
Date of changes:
1 April 2025
Version:
2.5
Year:
2021
Region / city:
Victoria, Australia
Theme:
Pharmacist regulations
Document type:
Legislative guideline
Agency / institution:
Medicines and Poisons Regulation (MPR)
Author:
Medicines and Poisons Regulation (MPR)
Target audience:
Health practitioners, pharmacists
Period of validity:
Ongoing
Approval date:
2017
Date of amendments:
2021
Context:
This document provides guidelines for pharmacists regarding the dispensing, administration, and supply of Schedule 4 and 8 medicines in Victoria, Australia, as outlined in the Drugs Poisons and Controlled Substances Act 1981 and related regulations.
Year:
2020
Region / city:
UK
Theme:
Medicines Information
Document type:
List
Organization / institution:
NHS
Author:
UKMi
Target audience:
NHS Medicines Information Services
Period of validity:
Ongoing, updated quarterly
Approval date:
November 2020
Date of changes:
May 2020
Note:
Year
Subject:
Medicine Formularies, Health Policy
Document Type:
Form, Application
Institution:
Ministry of Health
Author:
Applicant (Consultant, Specialist, Medical Officer, Pharmacist)
Target Audience:
Healthcare Professionals, Drug and Therapeutic Committee
Context:
Form used to propose the inclusion of a medicine or indication from the Ministry of Health Medicines Formulary into an institution’s Medicines Formulary for approval by the institution’s Drug and Therapeutic Committee.
Year:
Not specified
Region / City:
Malaysia
Topic:
Pharmaceutical registration and formulary listing
Document Type:
Application Form
Organization / Institution:
Ministry of Health Malaysia
Author:
Not specified
Target Audience:
Pharmaceutical companies, regulatory authorities
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Amendments:
Not specified